New drug approval success rate in Europe in 2009

被引：27

作者：

Eichler, Hans-Georg ^{[1
]}

Aronsson, Bo ^{[1
]}

Abadie, Eric ^{[2
]}

Salmonson, Tomas ^{[3
]}

机构：

[1] EMA, London E14 4HB, England

[2] Afssaps, Gen Directorate, F-93285 St Denis, France

[3] Lakemedelsverket Med Prod Agcy, SE-75103 Uppsala, Sweden

来源：

NATURE REVIEWS DRUG DISCOVERY | 2010年 / 9卷 / 05期

关键词：

D O I：

10.1038/nrd3169

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：355 / 356

页数：2

共 9 条

[1] Drug approvals and failures: implications for alliances [J].

Czerepak, Elizabeth A. ;

Ryser, Stefan .

NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (03) :197-198

[2] Balancing early market access to new drugs with the need for benefit/risk data: a mounting dilemma [J].

Eichler, Hans-Georg ;

Pignatti, Francesco ;

Flamion, Bruno ;

Leufkens, Hubert ;

Breckenridge, Alasdair .

NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (10) :818-826

[3]

*EUR COMM, 2005, NOT APPL A, V2, pCH1

[4]

*EUR MD AG, 2008, WITHDR ASS REP VOR M

[5]

*EUR MED AG, 2010, HUM MED

[6]

European Medicines Agency, 2008, REFL PAP BEN RISK AS

[7] 2009 FDA drug approvals [J].

Hughes, Bethan .

NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (02) :89-92

[8] The review of drug applications submitted to the European Medicines Evaluation Agency: frequently raised objections, and outcome [J].

Pignatti, F ;

Aronsson, B ;

Gate, N ;

Vamvakas, S ;

Wade, G ;

Moulon, I ;

Le Courtois, P .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 58 (09) :573-580

[9] Factors associated with success of market authorisation applications for pharmaceutical drugs submitted to the European Medicines Agency [J].

Regnstrom, Jan ;

Koenig, Franz ;

Aronsson, Bo ;

Reimer, Tatiana ;

Svendsen, Kristian ;

Tsigkos, Stelios ;

Flamion, Bruno ;

Eichler, Hans-Georg ;

Vamvakas, Spiros .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 66 (01) :39-48

← 1 →